Novartis sells stake in joint venture to GSK for $13 billion

News Image

MG News | March 27, 2018 at 01:02 PM GMT+05:00

0:00

Swiss pharmaceuticals giant Novartis announced Tuesday it will sell its stake it’s in its consumer healthcare joint venture to Britain's GlaxoSmithKline for $13 billion (10.4 billion euros).

The group said the sale of the 36.5 percent stake will enable it "to further focus on the development and growth of its core businesses."

It said the completion of the deal is expected in the second quarter of 2018, "subject to necessary approvals".

The two groups set up the consumer healthcare joint venture in 2015 following after a major reorganization of the Swiss group's drugs portfolio.

The split marks the first major transaction since Vas Narasimhan succeeded Joe Jimenez as chief executive last month.

"While our consumer healthcare joint venture with GSK is progressing well, the time is right for Novartis to divest a non-core asset at an attractive price," Narasimhan was quoted as saying in a company statement.

"This will strengthen our ability to allocate capital to grow our core businesses, drive shareholder returns, and execute value creating bolt-on acquisitions as we continue to build the leading medicines company, powered by digital and data."

The 2015 statement gave Novartis the right to offload the joint venture to GSK beginning this month, and GSK said the deal was motivated it could move forward with strategic business planning.

"Most importantly it also removes uncertainty and allows us to plan use of our capital for other priorities, especially pharmaceuticals" research and development, GSK's chief executive Emma Walmsley said in a statement.

Novartis in January reported that strong sales of two of its main blockbuster drugs enabled it to turn in a "good operational performance" in 2017.

Net profit climbed by 15 percent to $7.7 billion in 2017 on a one-percent increase in sales to $49.1 billion.

GlaxoSmithKline's net profits jumped 70 percent to £1.5 billion ($2.1 billion, 1.7 billion euros) last year on bumper sales – APP/AFP

Related News

Name Price/Vol %Chg/NChg
KSE100 136,502.54
259.91M
1.64%
2202.77
ALLSHR 85,079.90
838.35M
1.26%
1061.74
KSE30 41,552.62
97.27M
1.81%
738.33
KMI30 193,330.76
84.69M
0.39%
741.60
KMIALLSHR 56,315.31
366.02M
0.43%
243.06
BKTi 38,498.08
37.91M
4.13%
1526.33
OGTi 28,138.38
5.66M
-0.36%
-101.89
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 120,555.00 123,615.00
118,675.00
2025.00
1.71%
BRENT CRUDE 69.15 71.53
69.08
-1.21
-1.72%
RICHARDS BAY COAL MONTHLY 97.50 0.00
0.00
0.25
0.26%
ROTTERDAM COAL MONTHLY 106.50 106.60
106.50
-2.20
-2.02%
USD RBD PALM OLEIN 998.50 998.50
998.50
0.00
0.00%
CRUDE OIL - WTI 66.91 69.65
66.84
-1.54
-2.25%
SUGAR #11 WORLD 16.31 16.67
16.27
-0.26
-1.57%

Chart of the Day


Latest News
July 14, 2025 at 05:26 PM GMT+05:00

Gold price in Pakistan rises Rs1,600 per tola


July 14, 2025 at 04:59 PM GMT+05:00

Tax reforms focus on public ease, transparency


July 14, 2025 at 04:23 PM GMT+05:00

PSX Closing Bell: Another One Bites the High


July 14, 2025 at 04:06 PM GMT+05:00

PKR falls 25 paisa per USD



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg